Prognostic Evidence for Artificial Intelligence-Derived PET Tumour-Burden Biomarkers in Cancer: A Systematic Review
Background/Objectives: Artificial intelligence (AI) can automate tumour-burden measurement on positron emission tomography (PET), including metabolic tumour volume (MTV) and total metabolic tumour volume (TMTV). This review evaluated prognostic evidence for AI-derived PET tumour-burden biomarkers, particularly comparis...